Gilead signs six global pacts to make, sell generic HIV preventive drug
Gilead Sciences, Inc. has signed non-exclusive, royalty-freeĀ voluntary licensing agreementsĀ with six pharmaceutical makers to make and sell its generic lenacapavir drug for the prevention.